Yanhong Bu
Ministry of Education of the People's Republic of China(CN)Central South University(CN)Anhui University of Traditional Chinese Medicine(CN)Second Xiangya Hospital of Central South University(CN)
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, PI3K/AKT/mTOR signaling in cancer, Autophagy in Disease and Therapy, Immune cells in cancer, Cancer-related molecular mechanisms research
Most-Cited Works
- → Downregulated expression of miR-223 promotes Toll-like receptor-activated inflammatory responses in macrophages by targeting RhoB(2017)77 cited
- → Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases(2021)57 cited
- → Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro(2021)50 cited
- → Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2/PKC/ERK1/2-mediated SphK1 translocation(2022)46 cited
- → Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis(2020)37 cited
- → Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation